Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bone Marrow Transplantation

• Publication date

  2003-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1703928PMID 12732885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimized clinical-scale culture conditions for ex vivoselective depletion of host-reactive donor lymphocytes: astrategy for GVHD prophylaxis in allogeneic peripheral bloodstem cell transplantation

  2002cited by this paper
• Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

  2002cited by this paper
• Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐back

  2001cited by this paper
• Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

  2001cited by this paper
• Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

  2001cited by this paper
• The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation

  2000cited by this paper
• CD34+ cell dose predicts relapse and survival after T‐cell‐depleted HLA‐identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies

  2000cited by this paper
• Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

  2000cited by this paper
• Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study

  2000cited by this paper
• Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children

  1999cited by this paper
• Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

  1999cited by this paper
• Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.

  1992cited by this paper
• Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

  1991cited by this paper
• Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation.

  1988cited by this paper
• Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease.

  1987cited by this paper
• Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation

  1986cited by this paper
• Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

  1986cited by this paper
• Bone-marrow transplantation (first of two parts).

  1975cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Immunogenicity and Antibody Persistence of the Inactivated Quadrivalent Influenza Vaccine in Pediatric Patients Post-Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation Versus Healthy Controls

  2024influential citation
• Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro

  2023cites this paper
• British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

  2019cites this paper
• Immune reconstitution in cord blood transplantation

  2018cites this paper
• Inhibition of Vascular Adhesion Protein‐1 for Treatment of Graft‐Versus‐Host Disease in Mice

  2018cites this paper
• Cyclosporine A-Mediated IL-6 Expression Promotes Neural Induction in Pluripotent Stem Cells

  2017cites this paper
• Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients

  2017cites this paper
• A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.

  2016cites this paper
• of Stem Cell Research and Transplantation Characterization of Cyclosporine Concentrations and Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

  2015cites this paper
• Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation

  2014cites this paper
• driven graft-versus-leukemia effects - peptide following allogeneic stem cell transplantation and may improve PR1 chronic myeloid leukemia is associated with improved outcome High PR3 or ELA2 expression by CD34+ cells in advanced-phase

  2013cites this paper
• CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML

  2013cites this paper
• Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival

  2013cites this paper
• Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

  2013cites this paper
• acute lymphoblastic leukemia specific T lymphocytes after allogeneic stem-cell transplantation for - Graft-versus-leukemia effects associated with detectable Wilms tumor-1

  2013cites this paper
• Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

  2011cites this paper
• Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

  2010cites this paper
• Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation.

  2007cites this paper
• High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

  2007cites this paper
• Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant

  2007cites this paper
• Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

  2007cites this paper
• fficacy of CD 34 Stem Cell Dose in Patients ndergoing Allogeneic Peripheral Blood Stem Cell ransplantation after Total Body Irradiation

  2007cites this paper
• T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

  2006cites this paper
• High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

  2006cites this paper
• Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant.

  2006cites this paper
• Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

  2006cites this paper
• Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

  2006cites this paper
• Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

  2005cites this paper
• Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.

  2005cites this paper
• Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

  2005cites this paper
• Cyclosporine Inhibits the Development of Green Fluorescent Protein (GFP)-Specific Immune Responses After Transplantation of GFP-Expressing Hematopoietic Repopulating Cells in Dogs

  2005cites this paper
• Are stem cells and T cells best transplanted separately?

  2004cites this paper
• Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.

  2004cites this paper
• Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.

  2004cites this paper
• Phenotype of WT1-specific CD8 T cells

  year unknowncites this paper